KLA CORP

KLAC

Optical instruments and lenses

Last filing · Annual · Jun 30, 2026

35 more quarters with Pro

KLA CORP back to 2010, every line as filed.

USD ($) $ in Thousands	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022
Cash flows from operating activities:
Net income	$ 1,200,990	$ 1,145,682	$ 1,121,040	$ 1,088,416	$ 824,527	$ 945,851	$ 601,541	$ 582,534	$ 741,375	$ 697,837	$ 978,795	$ 1,026,065
Adjustments to reconcile net income to net cash provided by operating activities:
Impairment of goodwill and purchased intangible assets	0	0	-	0	239,100	-	70,474	219,000	-	-	-	-
Goodwill impairment	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization	99,088	99,268	97,016	98,091	103,922	95,823	99,263	99,063	102,403	104,854	103,508	101,938
Loss on extinguishment of debt	-	-	-	-	-	-	0	0	0	0	0	13,286
Unrealized foreign exchange loss and other	(14,000)	2,304	12,078	4,558	11,346	7,718	7,629	(34,346)	9,970	(16,531)	(20,679)	1,783
Asset impairment charges	-	-	-	-	-	-	-	-	0	-	749	9,156
Disposal of non-controlling interest	-	-	-	-	-	-	-	-	0	-	-	8,270
Other	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt and other, net	-	-	-	-	-	-	-	-	-	-	-	-
Net gain on sale of assets	(683)	-	-	-	(161)	-	-	-	-	-	-	-
Stock-based compensation expense	83,938	73,947	70,182	70,201	61,841	61,700	56,682	48,620	48,772	48,130	38,405	34,982
Gain on sale of business	-	-	-	-	-	-	-	-	0	-	-	(29,687)
Deferred income taxes	15,089	(31,728)	(10,615)	(35,437)	(68,976)	(81,682)	11,886	(65,158)	(71,322)	(66,596)	(98,890)	(156,226)
Excess tax benefit from equity awards	-	-	-	-	-	-	-	-	-	-	-	-
Net (gain) loss on sales of marketable securities and other investments	-	-	-	-	-	-	-	-	-	-	-	-
Changes in assets and liabilities:
Accounts receivable	(233,948)	191,158	(12,575)	185,975	(394,604)	(91,660)	194,311	(160,265)	107,018	342,090	(440,647)	(55,073)
Accounts receivable	-	-	-	-	-	-	-	-	-	-	-	-
Inventories	(159,135)	1,214	(95,738)	(112,283)	64,958	(59,326)	28,359	(21,189)	(138,419)	(211,216)	(127,647)	(265,530)
Other assets	(63,783)	(65,267)	50,921	14,309	(90,845)	152,641	(111,233)	(104,872)	(7,520)	(60,973)	(15,091)	45,637
Accounts payable	93,276	(5,027)	(23,680)	(12,227)	67,080	(12,463)	(10,238)	2,692	8,345	(119,606)	44,317	36,472
Deferred system revenue	(237,250)	39,285	1,974	(204,221)	195,357	(108,648)	110,442	218,250	14,057	(1,765)	95,079	(60,492)
Deferred service revenue	(41,737)	(22,082)	(4,970)	5,820	22,927	35,863	54,288	68,821	5,901	5,332	42,630	(12,411)
Deferred system profit	-	-	-	-	-	-	-	-	-	-	-	-
Deferred system profit	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities	(34,394)	(61,147)	(44,042)	(31,043)	(186,957)	49,421	(203,426)	(230,908)	63,160	289,299	87,761	313,375
Settlement of treasury lock agreement	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities	707,451	1,367,607	1,161,591	1,072,159	849,515	995,238	909,978	622,242	883,740	1,010,855	688,290	1,011,545
Cash flows from investing activities:
Acquisition of intellectual property	-	-	-	(2,850)	-	-	-	-	-	-	-	-
Proceeds from sale of assets	-	-	-	-	161	-	-	5,079	-	-	-	-
Net proceeds from sale of business	-	-	-	-	-	-	-	-	0	-	-	75,358
Acquisition of non-marketable securities	-	-	-	-	-	-	-	-	-	-	-	-
Business acquisitions, net of cash acquired	-	-	-	-	-	-	(3,682)	-	0	-	-	(27,144)
Capital expenditures	(85,187)	(105,576)	(95,894)	(82,135)	(92,323)	(60,393)	(71,793)	(76,801)	(68,045)	(84,914)	(93,642)	(84,352)
Proceeds from capital-related government assistance	-	15,241	1,541	315	-	-	-	-	-	-	-	-
Purchases of available-for-sale and equity securities	(1,039,202)	(861,613)	(949,871)	(697,596)	(489,033)	(837,935)	(1,172,264)	(451,800)	(530,842)	(402,672)	(301,372)	(256,793)
Proceeds from maturity and sale of available-for-sale securities	639,625	840,909	632,795	-	-	-	-	-	-	-	-	-
Purchases of available-for-sale securities	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of available-for-sale securities	-	-	-	93,085	183,097	55,322	55,722	7,252	7,983	37,786	10,147	26,608
Proceeds from maturity of available-for-sale securities	-	-	-	378,471	1,010,660	671,925	342,808	427,128	201,149	345,972	141,926	211,465
Purchases of trading securities	(48,919)	(23,944)	(156,864)	(53,418)	(17,276)	(17,581)	(46,456)	(16,049)	(49,958)	(40,176)	(18,071)	(19,512)
Proceeds from sale of trading securities	36,924	22,301	158,305	43,341	18,420	17,623	37,619	16,715	48,042	30,797	19,607	19,875
Other, net	2,451	-	-	-	-	-	-	-	-	-	-	-
Proceeds from other investments	-	-	-	984	-	-	-	-	0	-	-	1,020
Net cash provided by (used in) investing activities	(494,308)	(112,682)	(409,988)	(319,803)	613,706	(171,039)	(858,046)	(88,476)	(391,671)	(113,207)	(241,405)	(53,475)
Cash flows from financing activities:
Payment of debt issuance costs	-	-	(1,602)	-	-	-	-	-	0	-	-	(6,515)
Proceeds from revolving credit facility	-	-	-	-	-	-	-	-	0	-	-	300,000
Repayment of debt	-	-	-	-	(750,000)	-	-	-	0	(225,000)	(200,000)	(662,250)
Proceeds from issuance of debt, net of issuance costs	-	-	-	-	-	-	735,043	-	-	-	-	-
Tax withholding payments related to vested and released restricted stock units	(4,362)	(5,717)	(81,122)	(2,680)	(3,608)	(72,246)	(24,274)	(3,005)	(68,237)	(16,154)	(2,598)	(54,952)
Common stock repurchases	(625,955)	(547,750)	(545,067)	(506,745)	(650,121)	(567,383)	(372,251)	(437,817)	(455,412)	(478,186)	(355,007)	(89,846)
Payment of dividends to stockholders	(248,836)	(249,654)	(254,008)	(225,774)	(226,776)	(198,079)	(197,154)	(196,859)	(181,507)	(180,854)	(184,208)	(187,984)
Issuance of common stock	1	55,542	-	-	47,538	-	-	48,433	0	-	33,793	115
Contingent consideration payable and other, net	-	-	-	-	-	-	(2,440)	(1,676)	-	(2,527)	(2,500)	-
Purchase of non-controlling interest	-	-	-	-	-	-	-	-	0	-	-	(4,295)
Payment of contingent consideration payable	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefit from equity awards	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities	(879,152)	(747,579)	(881,799)	(735,199)	(1,582,967)	(837,708)	138,924	(590,924)	(705,156)	(902,721)	(710,520)	(705,727)
Effect of exchange rate changes on cash and cash equivalents	895	(1,433)	(2,501)	2,587	(19,178)	13,582	(7,743)	10,642	(3,208)	2,109	15,832	(17,971)
Net decrease in cash and cash equivalents	(665,114)	505,913	(132,697)	19,744	(138,924)	73	183,113	(46,516)	(216,295)	(2,964)	(247,803)	234,372
Supplemental cash flow disclosures:
Income taxes paid, net	179,496	283,901	119,049	197,594	361,833	96,395	159,848	506,046	99,388	56,779	293,403	101,061
Income taxes paid	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid, net of capitalized interest	131,392	7,700	131,494	128,814	25,059	131,126	113,372	24,818	113,236	125,055	29,635	44,216
Non-cash activities:
Contingent consideration payable - financing activities	-	-	-	-	-	0	-	155	(920)	(75)	(1,919)	145
Business acquisition holdback amounts - investing activities	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for the acquisition of Orbotech Ltd. - financing activities	-	-	-	-	-	-	-	-	-	-	-	-
Dividends payable - financing activities	-	-	-	-	-	2,009	2,105	2,132	1,853	1,915	1,999	1,942
Unsettled common stock repurchase - financing activities	(1)	(14,707)	20,207	(1)	1	5,499	-	(1)	11,000	(32)	15,975	0
Accrued debt issuance costs - financing activities	-	-	-	-	-	-	-	-	-	-	-	-
Accrued purchases of land, property and equipment - investing activities	$ 5,901	$ (6,718)	$ 32,758	$ 12,968	$ (2,495)	$ 13,849	$ (2,934)	$ (4,417)	$ 22,729	$ (16,200)	$ (3,437)	$ 34,027